Reagents and methods for detecting HCV
US11987851B2 · kind B2 · utility
0Cited by
2References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 17, 2021 |
| Grant date | May 21, 2024 |
| Priority date | — |
| Expiry date | Feb 4, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Q1/707
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present disclosure relates to oligonucleotide sequences for amplification primers and their use in performing nucleic acid amplifications of HCV, in particular regions that encode the NS3 polypeptide. In some embodiments the primers are used in nested PCR methods for the detection or sequencing of HCV NS3. The oligonucleotide sequences are also provided assembled as kits that can be used to amplify and detect or sequence HCV NS3.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.